The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL.

Purpose: To evaluate the long-term (>1 yr) outcomes a non-diffractive extended vision intraocular lens (AcrySof IQ Vivity) compared to monofocal control.

Setting: This was a multicenter trial that took place in 4 separate private ophthalmology practices throughout the United States.

Design: This was a prospective, non-interventional, controlled, multicenter trial.

Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design.

Purpose: To evaluate the effectiveness and safety of the DFT015 intraocular lens (IOL) (AcrySof IQ Vivity Extended Vision) compared with an aspheric monofocal control IOL (AcrySof IQ model SN60WF).

Setting: 11 investigation sites in the U.S.

Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of a Non-Diffractive Extended Vision Intraocular Lens with a Target of Slight Myopia in the Non-Dominant Eye.

Purpose: To assess the visual outcomes and quality of vision of patients receiving the AcrySof IQ Vivity™ non-diffractive extended vision intraocular lens (NDEV IOL) after uneventful cataract surgery when the non-dominant eye is targeted for slight myopia.

Design: Single site, prospective, single-arm study.

Methods: Eligible subjects interested in reducing their dependence on spectacles over a range of working distances were enrolled and followed for 3 months after the second eye surgery.